Keros Therapeutics Inc (KROS)
$11.04 -2.82% Close Oct 30, 2026 Live
Keros Therapeutics stock today
Keros Therapeutics closed at $11.04 on October 30, 2026, down 2.82% on the day. Over the past year it returned -26.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $219 million.
$10.00$15.00$20.00
NovJan 2026MarMayJulSep
| Period | KROS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.2% | -0.9% |
| 3 months | +8.0% | +2.1% |
| Year to date | -45.8% | +11.7% |
| 1 year | -26.5% | +12.4% |
| 3 years | -60.6% | +88.5% |
| 5 years | -73.5% | +76.0% |
Key statistics
- Market value
- $219M
- Price / sales
- 14.6
- 52-week range
- $9.91 to $21.84
- Next report
- Nov 4, 2026 (estimated)
About Keros Therapeutics
Develops therapeutic treatments for genetic and metabolic diseases.
Sector: Health Care
More on Keros Therapeutics
- Financials: revenue, earnings and segmentsRevenue +6,775% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $264.62 today
No forecast, no recommendation. This page describes Keros Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.